Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **gallbladder and biliary tract** together comprise the system responsible for the storage, concentration, and controlled release of bile, which is produced by the liver and important for the digestion and absorption of dietary fats. The gallbladder is a small, pear-shaped organ situated under the liver, connected via the cystic duct to the common bile duct, which transports bile to the duodenum[7][5][1][3][9]. The biliary tract includes intrahepatic and extrahepatic bile ducts—the anatomical system that carries bile from the liver and gallbladder to the intestine. The gallbladder and biliary tract are frequent sites of disease, including gallstones, infection, inflammatory disease, and several forms of cancer (especially gallbladder cancer and cholangiocarcinoma)[2][4][6][8]. However, as an anatomical-organ system, this is not a molecular drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gallbladder and biliary tract.